BioCardia, Inc. Insider Trading

BCDA

⊜ Compare

Last 12 months

Insiders bought 170K on the open market and sold nothing.

Net open-market

+170K

23 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

Oct 2026

Oct 16, 2026

Get an email when BCDA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 15 – 16	Peter Altman President and CEO	Bought 2 parts	500	$0.95 average	$475	0.1%	Form 4
Sep 29	Peter Altman President and CEO	Bought	1,000	$1.03	1K	0.3%	Form 4
Sep 23	Peter Altman President and CEO	Bought	1,900	$1.05	2K	0.5%	Form 4
Sep 3	Peter Altman President and CEO	Bought	800	$1.09	$872	0.2%	Form 4
Aug 17	Peter Altman President and CEO	Bought	5,400	$0.93	5K	1.4%	Form 4
Aug 13	Peter Altman President and CEO	Bought	1,900	$0.92	2K	0.5%	Form 4
Jul 29	Peter Altman President and CEO	Bought	5,000	$0.78	4K	1.4%	Form 4
Jul 17	Peter Altman President and CEO	Bought	500	$0.83	$415	0.1%	Form 4
Jul 14 – 15	Peter Altman President and CEO	Bought 2 parts	4,300	$0.87 average	4K	1.2%	Form 4
Jul 8 – 10	Peter Altman President and CEO	Bought 3 parts	7,500	$0.96 average	7K	2.1%	Form 4
Jul 8	Peter Altman President and CEO	Bought	5,400	$0.96	5K	1.5%	Form 4
Jun 22 – 23	Simon H Stertzer Director	Bought 2 parts	109,200	$0.95 average	104K	189%	Form 4
Jun 17 – 18	Peter Altman President and CEO	Bought 2 parts	2,300	$0.89 average	2K	0.8%	Form 4
Jun 9	Peter Altman President and CEO	Bought	5,000	$0.85	4K	1.7%	Form 4
May 19 – 20	Peter Altman President and CEO	Bought 2 parts	1,700	$0.92 average	2K	0.6%	Form 4
May 18	Peter Altman President and CEO	Bought	5,700	$0.92	5K	2.0%	Form 4
May 15	Peter Altman President and CEO	Bought	5,100	$1.02	5K	1.8%	Form 4
Apr 29	Peter Altman President and CEO	Bought	5,000	$1.11	6K	1.8%	Form 4
Apr 20 – 21	Peter Altman President and CEO	Bought 2 parts	1,000	$1.23 average	1K	0.4%	Form 4
Mar 24 – 25	Peter Altman President and CEO	Bought 2 parts	900	$1.23 average	1K	0.3%	Form 4
Feb 4	Peter Altman President and CEO	Bought	5,000	$1.13	6K	1.9%	Form 4
Jan 20 – 21	Peter Altman President and CEO	Bought 2 parts	900	$1.33 average	1K	0.3%	Form 4
Dec 16, 2025 – Dec 17, 2025	Peter Altman President and CEO	Bought 2 parts	1,100	$1.31 average	1K	0.4%	Form 4
Sep 19, 2025	Simon H Stertzer Director	Bought	398,400	$1.25	498K	156%	Form 4
Sep 19, 2025	Andrew Scott Blank Director	Bought	288,000	$1.25	360K	83%	Form 4
Sep 19, 2025	Peter Altman President and CEO	Bought	48,000	$1.25	60K	28%	Form 4
Aug 22, 2025	Peter Altman President and CEO	Bought	700	$1.83	1K	0.4%	Form 4
Aug 13, 2025	Peter Altman President and CEO	Bought	100	$1.83	$183	<0.1%	Form 4
Aug 12, 2025	Peter Altman President and CEO	Bought	400	$1.75	$700	0.2%	Form 4
Aug 11, 2025	Peter Altman President and CEO	Bought	1,700	$1.76	3K	1.0%	Form 4
Jun 30, 2025	David McClung Chief Financial Officer	Bought	4,819	$2.08	10K	11%	Form 4
Jun 30, 2025	Peter Altman President and CEO	Bought	24,096	$2.08	50K	17%	Form 4
Jun 30, 2025	Simon H Stertzer Director	Bought	72,289	$2.08	150K	39%	Form 4
Jun 30, 2025	Andrew Scott Blank Director	Bought	72,289	$2.08	150K	26%	Form 4
May 30, 2025	Peter Altman President and CEO	Bought	100	$2.21	$221	<0.1%	Form 4
May 20, 2025 – May 22, 2025	Peter Altman President and CEO	Bought 2 parts	2,300	$2.02 average	5K	1.7%	Form 4
May 14, 2025 – May 16, 2025	Peter Altman President and CEO	Bought 2 parts	400	$2.57 average	1K	0.3%	Form 4
Apr 23, 2025	Richard M Krasno Director	Bought	13,123	$1.91	25K	417%	Form 4
Apr 23, 2025	David McClung Chief Financial Officer	Bought	13,123	$1.91	25K	44%	Form 4
Apr 23, 2025	Bill Facteau Director	Bought	13,123	$1.91	25K	New	Form 4

Oct 15 – 16
Peter Altman
President and CEO · bought 500 at avg $0.95
$475
0.1% of stake
Sep 29
Peter Altman
President and CEO · bought 1,000 at $1.03
1K
0.3% of stake
Sep 23
Peter Altman
President and CEO · bought 1,900 at $1.05
2K
0.5% of stake
Sep 3
Peter Altman
President and CEO · bought 800 at $1.09
$872
0.2% of stake
Aug 17
Peter Altman
President and CEO · bought 5,400 at $0.93
5K
1.4% of stake
Aug 13
Peter Altman
President and CEO · bought 1,900 at $0.92
2K
0.5% of stake
Jul 29
Peter Altman
President and CEO · bought 5,000 at $0.78
4K
1.4% of stake
Jul 17
Peter Altman
President and CEO · bought 500 at $0.83
$415
0.1% of stake
Jul 14 – 15
Peter Altman
President and CEO · bought 4,300 at avg $0.87
4K
1.2% of stake
Jul 8 – 10
Peter Altman
President and CEO · bought 7,500 at avg $0.96
7K
2.1% of stake
Jul 8
Peter Altman
President and CEO · bought 5,400 at $0.96
5K
1.5% of stake
Jun 22 – 23
Simon H Stertzer
Director · bought 109,200 at avg $0.95
104K
189% of stake
Jun 17 – 18
Peter Altman
President and CEO · bought 2,300 at avg $0.89
2K
0.8% of stake
Jun 9
Peter Altman
President and CEO · bought 5,000 at $0.85
4K
1.7% of stake
May 19 – 20
Peter Altman
President and CEO · bought 1,700 at avg $0.92
2K
0.6% of stake
May 18
Peter Altman
President and CEO · bought 5,700 at $0.92
5K
2.0% of stake
May 15
Peter Altman
President and CEO · bought 5,100 at $1.02
5K
1.8% of stake
Apr 29
Peter Altman
President and CEO · bought 5,000 at $1.11
6K
1.8% of stake
Apr 20 – 21
Peter Altman
President and CEO · bought 1,000 at avg $1.23
1K
0.4% of stake
Mar 24 – 25
Peter Altman
President and CEO · bought 900 at avg $1.23
1K
0.3% of stake
Feb 4
Peter Altman
President and CEO · bought 5,000 at $1.13
6K
1.9% of stake
Jan 20 – 21
Peter Altman
President and CEO · bought 900 at avg $1.33
1K
0.3% of stake
Dec 16, 2025 – Dec 17, 2025
Peter Altman
President and CEO · bought 1,100 at avg $1.31
1K
0.4% of stake
Sep 19, 2025
Simon H Stertzer
Director · bought 398,400 at $1.25
498K
156% of stake
Sep 19, 2025
Andrew Scott Blank
Director · bought 288,000 at $1.25
360K
83% of stake
Sep 19, 2025
Peter Altman
President and CEO · bought 48,000 at $1.25
60K
28% of stake
Aug 22, 2025
Peter Altman
President and CEO · bought 700 at $1.83
1K
0.4% of stake
Aug 13, 2025
Peter Altman
President and CEO · bought 100 at $1.83
$183
<0.1% of stake
Aug 12, 2025
Peter Altman
President and CEO · bought 400 at $1.75
$700
0.2% of stake
Aug 11, 2025
Peter Altman
President and CEO · bought 1,700 at $1.76
3K
1.0% of stake
Jun 30, 2025
David McClung
Chief Financial Officer · bought 4,819 at $2.08
10K
11% of stake
Jun 30, 2025
Peter Altman
President and CEO · bought 24,096 at $2.08
50K
17% of stake
Jun 30, 2025
Simon H Stertzer
Director · bought 72,289 at $2.08
150K
39% of stake
Jun 30, 2025
Andrew Scott Blank
Director · bought 72,289 at $2.08
150K
26% of stake
May 30, 2025
Peter Altman
President and CEO · bought 100 at $2.21
$221
<0.1% of stake
May 20, 2025 – May 22, 2025
Peter Altman
President and CEO · bought 2,300 at avg $2.02
5K
1.7% of stake
May 14, 2025 – May 16, 2025
Peter Altman
President and CEO · bought 400 at avg $2.57
1K
0.3% of stake
Apr 23, 2025
Richard M Krasno
Director · bought 13,123 at $1.91
25K
417% of stake
Apr 23, 2025
David McClung
Chief Financial Officer · bought 13,123 at $1.91
25K
44% of stake
Apr 23, 2025
Bill Facteau
Director · bought 13,123 at $1.91
25K
New position

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BCDA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with BCDA

CompareIntrinsic value

PLXProtalix Biotherapeutics Inc.

$2.69+3.07%68

ALLOAllogene Therapeutics Inc.

$1.19+6.25%10

ATRAAtara Biotherapeutics, Inc.

$8.37+2.07%15

ELOXEloxx Pharmaceuticals, Inc.

$12.74-1.39%20

CCCCC4 Therapeutics Inc.

$3.12-2.80%33

AUTLAutolus Therapeutics plc

$1.38-2.83%40

TSHATaysha Gene Therapies Inc.

$4.36+6.60%40

CRDFCardiff Oncology Inc.

$0.87+1.03%36

Spot a number that looks wrong? Check it in BCDA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BCDA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.